Periodic Reporting for period 1 - BIOSTAB-DIFF (Controlling cellular differentiation of industrial enzyme production in Bacillus subtilis)
Período documentado: 2023-09-01 hasta 2025-08-31
The overall objective was to investigate and control cellular heterogeneity in B. subtilis for biotechnological applications. Specific goals were: (1) to construct and characterize sporulation-deficient strains (ΔspoIIE and ΔsigF), (2) assess the impact of these genetic modifications on growth and fitness, (3) evaluate enzyme production under controlled fermentation conditions, (4) optimize nutrient formulations for maximizing yield and secretion stability, and (5) disseminate findings through publications, presentations, and training.
Key findings include:
ΔspoIIE supported higher and more stable enzyme production than ΔsigF, validating early sporulation blockade as an effective strategy.
Optimal nutrient conditions (1% glucose + 2% yeast extract) balanced growth with secretion efficiency.
Raffinose acted as a secretion stabilizer rather than a primary carbon source, contributing to consistent enzyme titers.
Combined genetic and nutrient strategies provided a clear proof-of-concept for controlling bistability to enhance industrial enzyme production.
Deliverables achieved included construction and validation of mutant strains, comprehensive growth and secretion profiling, and identification of high-yield conditions. A manuscript is in preparation for submission to Microbial Cell Factories. Dissemination included a presentation at the Swammerdam Institute for Life Sciences seminar, and preliminary findings were integrated into other research lines within the host group.
The discovery that raffinose functions as a secretion stabilizer is also innovative, offering new opportunities for fermentation design. Together, these results advance microbial biotechnology, synthetic biology, and industrial fermentation by showing how cellular differentiation can be managed to achieve stable high-yield enzyme production.
Applications include:
Bioprocess optimization: reduced sporulation-related variability, lower costs, and improved efficiency.
Food and pharmaceutical industries: more reliable enzyme supply for processing applications.
Sustainable biomanufacturing: alignment with the European Green Deal through resource efficiency and reduced environmental footprint.
The work also strengthened the researcher’s expertise in microbial genetics, fermentation, and dissemination, supporting career development toward independent leadership in enzyme biotechnology.